Avanir Offering Brings $25M For Neurodex NDA, Pipeline May 27, 2004 By Karen Carey No Comments As it nears a new drug application filing for its second product, Avanir Pharmaceuticals Inc. priced a $25 million common stock offering that will allow it to continue development of its pipeline products. (BioWorld Today)Read More
Bioniche Growing Manufacturing In Ireland Through $13M In Loans May 25, 2004 By Karen Carey No Comments
